Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues:
Premiums	$ 21,003	$ 18,984	$ 63,894	$ 56,927
Net investment income	201	246	515	832
Total revenues	81,159	73,794	238,621	215,507
Operating costs:
Cost of products sold	50,365	45,011	145,164	129,425
Benefit costs	17,419	16,081	52,976	47,686
Opioid litigation charges	5,220	0	5,704	0
Loss on assets held for sale	2,480	0	2,521	0
Goodwill impairment	0	431	0	431
Operating expenses	9,606	9,210	28,128	27,001
Total operating costs	85,090	70,733	234,493	204,543
Operating income (loss)	(3,931)	3,061	4,128	10,964
Interest expense	566	602	1,735	1,895
Loss on early extinguishment of debt	0	363	0	363
Other income	(41)	(49)	(126)	(144)
Income (loss) before income tax provision	(4,456)	2,145	2,519	8,850
Income tax provision (benefit)	(1,047)	558	654	2,248
Net income (loss)	(3,409)	1,587	1,865	6,602
Net (income) loss attributable to noncontrolling interests	(7)	11	(18)	2
Net income (loss) attributable to CVS Health	$ (3,416)	$ 1,598	$ 1,847	$ 6,604
Net income (loss) per share attributable to CVS Health:
Basic (in dollars per share)	$ (2.60)	$ 1.21	$ 1.41	$ 5.01
Diluted (in dollars per share)	$ (2.60)	$ 1.20	$ 1.40	$ 4.98
Weighted average shares outstanding:
Basic (in shares)	1,315	1,321	1,313	1,318
Diluted (in shares)	1,315	1,329	1,324	1,326
Dividends declared per share (in dollars per share)	$ 0.55	$ 0.50	$ 1.65	$ 1.50
Cost, Product and Service [Extensible List]	Products	Products	Products	Products
Products
Revenues:
Revenues	$ 57,643	$ 51,853	$ 166,959	$ 149,765
Services
Revenues:
Revenues	$ 2,312	$ 2,711	$ 7,253	$ 7,983